M.C. del Cañizo

2.1k citations
51 papers · 1.4k indexed · h-index 19
Topics
Acute Myeloid Leukemia Research (21 papers)Mesenchymal stem cell research (13 papers)Hematopoietic Stem Cell Transplantation (13 papers)

In The Last Decade

M.C. del Cañizo

49 papers receiving 1.4k citations

Peers

M.C. del Cañizo
Comparison fields: 5 of 85
  • Genetics 723
  • Hematology 632
  • Molecular Biology 254
  • Rheumatology 250
  • Surgery 228
Replace Eva M. Villarón with:
Eva M. Villarón Spain
Eva Zetterberg Sweden
Joan García‐López Spain
Katarina LeBlanc Sweden
Alwine B. Kruisselbrink Netherlands
Attila Szakos Sweden
Steve Devine United States
R. Laylor United Kingdom
María Díez‐Campelo Spain
Juan F. Blanco Spain
M.C. del Cañizo relative to Eva M. Villarón Spain Eva M. Villarón's profile →
Citations per field
00.5×1.7×
Eva M. Villarón · 1×
Citations per year

Countries citing papers authored by M.C. del Cañizo

Since Specialization
Citations

This map shows the geographic impact of M.C. del Cañizo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. del Cañizo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. del Cañizo more than expected).

Fields of papers citing papers by M.C. del Cañizo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. del Cañizo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. del Cañizo. The network helps show where M.C. del Cañizo may publish in the future.

Co-authorship network of co-authors of M.C. del Cañizo

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. del Cañizo. A scholar is included among the top collaborators of M.C. del Cañizo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. del Cañizo. M.C. del Cañizo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 36
2 28
3 244
4 22
5 11
6 3
7 39
8 6
9 12
10 13
11 38
12 17
13 0
14 7
15 90
16 17
17 3
18 78
19 18
20 28

About M.C. del Cañizo

M.C. del Cañizo is a scholar working on Hematology, Genetics and Transplantation, having authored 51 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Mesenchymal stem cell research (13 papers) and Hematopoietic Stem Cell Transplantation (13 papers). The work is most often cited by research in Genetics (723 citations), Hematology (632 citations) and Urology (149 citations). M.C. del Cañizo has collaborated with scholars based in Spain, Netherlands and United States. Frequent co-authors include Jesús F. San Miguel, Fermín Sánchez‐Guijo, Marcos González, Natalia López-Holgado, Juan F. Blanco, Eva M. Villarón, María Díez‐Campelo, Josè Antonio Pérez-Simón, Soraya Carrancio and Júlia Almeida. Their work appears in journals such as Blood, PLoS ONE and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026